Autoimmune Diseases  >>  Tekturna (aliskiren)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tekturna (aliskiren) / PDL
NCT00922311: Aliskiren for Proteinuric IgAN Despite Angiotensin Blockade

Checkmark Data
Mar 2011 - Mar 2011: Data
Completed
4
25
RoW
Aliskiren, Rasilez
The University of Hong Kong, Queen Mary Hospital, Hong Kong, United Christian Hospital
IgA Nephropathy
12/10
12/10
NCT01129557: Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease

Terminated
4
46
US
Aliskiren, Tekturna, Valsartan, Diovan
Columbia University, Novartis Pharmaceuticals
Proteinuric Kidney Disease, Diabetic Nephropathy, Hypertensive Nephrosclerosis, IgA Nephropathy, Focal Segmental Glomerulosclerosis, Glomerulopathy (Obesity-associated), Glomerulonephritis, Membranous
01/12
12/12

Download Options